Radiation-boosted immunotherapy shows promise against advanced lung cancer

NCT ID NCT04245514

Ongoing Disease control Sponsor: Swiss Cancer Institute Source: ClinicalTrials.gov ↗

First seen Apr 04, 2026 · Last updated May 13, 2026 · Updated 3 times

Summary

This study tests whether adding a special type of radiotherapy to standard chemotherapy and immunotherapy before surgery can improve outcomes for people with stage III lung cancer that has spread to lymph nodes. About 90 participants will receive one of three radiation schedules alongside the drugs. The goal is to see if this combination reduces the chance of cancer returning or spreading.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Hôpitaux Universitaires de Genève

Geneva, 1211, Switzerland
IOSI Ospedale Regionale di Bellinzona e Valli

Bellinzona, 6500, Switzerland
Inselspital

Bern, 3010, Switzerland
Kantonsspital - St. Gallen

Sankt Gallen, CH-9007, Switzerland
Kantonsspital Aarau

Aarau, CH-5001, Switzerland
Kantonsspital Baden

Baden, 5404, Switzerland
Kantonsspital Graubuenden

Chur, CH-7000, Switzerland
Regionalspital Thun

Thun, 3600, Switzerland
St. Claraspital Basel

Basel, 4016, Switzerland
Stadtspital Triemli

Zurich, 8063, Switzerland
Universitaetsspital Basel

Basel, 4031, Switzerland
Universitätsklinikum Tübingen

Tübingen, 72076, Germany
Universitätsspital Zuerich

Zurich, 8091, Switzerland

Conditions

Explore the condition pages connected to this study.

NON SMALL CELL LUNG CANCER NSCLC